https://scholars.lib.ntu.edu.tw/handle/123456789/640063
標題: | An algorithm for simplified hepatitis C virus treatment with non-specialist care based on nation-wide data from Taiwan | 作者: | Yu, Ming-Lung Tai, Chi-Ming Mo, Lein-Ray Kuo, Hsing-Tao Huang, Chung-Feng Tseng, Kuo-Chih Lo, Ching-Chu Bair, Ming-Jong Wang, Szu-Jen Huang, Jee-Fu Yeh, Ming-Lun Chen, Chun-Ting Tsai, Ming-Chang Huang, Chien-Wei Lee, Pei-Lun Yang, Tzeng-Hue Huang, Yi-Hsiang Chong, Lee-Won Chen, Chien-Lin Yang, Chi-Chieh Hung, Chao-Hung Yang, Sheng-Shun Cheng, Pin-Nan Hsieh, Tsai-Yuan Hu, Jui-Ting Wu, Wen-Chih Cheng, Chien-Yu Chen, Guei-Ying Zhou, Guo-Xiong Tsai, Wei-Lun Kao, Chien-Neng Lin, Chih-Lang Wang, Chia-Chi Lin, Ta-Ya Lin, Chih-Lin Su, Wei-Wen Lee, Tzong-Hsi Chang, Te-Sheng CHUN-JEN LIU Dai, Chia-Yen Chen, Chi-Yi JIA-HORNG KAO Lin, Han-Chieh Chuang, Wan-Long Peng, Cheng-Yuan |
關鍵字: | American Association for the Study of Liver Diseases and the Infectious Diseases Society of America; Direct-acting antivirals; European Association for the Study of the Liver; Laboratory abnormalities; Liver function; Safety; Simplified treatment; Taiwan hepatitis C registry; glecaprevir/pibrentasvir; sofosbuvir/velpatasvir | 公開日期: | 21-一月-2024 | 來源出版物: | Hepatology international | 摘要: | Both European Association for the Study of the Liver (EASL) and American Association for the Study of Liver Diseases and the Infectious Diseases Society of America (AASLD-IDSA) guidelines recommend simplified hepatitis C virus (HCV) treatment with pan-genotypic sofosbuvir/velpatasvir or glecaprevir/pibrentasvir for eligible patients. This observational study used real-world data to assess these regimens' safety in eligible patients and develop an algorithm to identify patients suitable for simplified treatment by non-specialists. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/640063 | ISSN: | 19360533 | DOI: | 10.1007/s12072-023-10609-7 |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。